ALIN Trademark

Trademark Overview


On Thursday, December 19, 2013, a trademark application was filed for ALIN with the United States Patent and Trademark Office. The USPTO has given the ALIN trademark a serial number of 86148901. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 22, 2022. This trademark is owned by Productos Farmaceuticos, S.A. de C.V.. The ALIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory; immunosuppressive and anti-allergic actions, alon...
alin

General Information


Serial Number86148901
Word MarkALIN
Filing DateThursday, December 19, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 22, 2022
Registration Number4824753
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory; immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis; scleritis, uveitis/iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival/corneal physical/chemical burning, inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea/vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
Translation of Words in MarkThe English translation of the word "ALIN" in the mark is "LOWEST".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProductos Farmaceuticos, S.A. de C.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMexico, D.F. 11520
MX

Party NameProductos Farmaceuticos, S.A. de C.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMexico, D.F. 11520
MX

Party NameProductos Farmaceuticos, S.A. de C.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMexico, D.F. 11520
MX

Trademark Events


Event DateEvent Description
Friday, April 22, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 20151(B) BASIS DELETED; NEW BASIS REQUESTED
Monday, June 15, 2015NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 3, 2015ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, June 3, 2015PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, June 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Friday, May 22, 2015SOU EXTENSION 1 FILED
Friday, May 29, 2015ASSIGNED TO PETITION STAFF
Friday, May 22, 2015TEAS EXTENSION RECEIVED
Friday, May 22, 2015TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, November 25, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 30, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 21, 2014ASSIGNED TO LIE
Wednesday, August 13, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, August 13, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 13, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, August 13, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, June 27, 2014ASSIGNED TO EXAMINER
Thursday, June 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 5, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 1, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2014NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2014NON-FINAL ACTION WRITTEN
Tuesday, April 1, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2014NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2014NON-FINAL ACTION WRITTEN
Wednesday, March 26, 2014ASSIGNED TO EXAMINER
Tuesday, January 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 23, 2013NEW APPLICATION ENTERED IN TRAM